• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Novo Nordisk A/S ADR (NY: NVO )

    135.42 -5.45 (-3.87%)
    Official Closing Price Updated: 7:00 PM EDT, Jul 17, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 6,703,872
    Open 136.41
    Bid (Size) 135.00 (4)
    Ask (Size) 136.00 (1)
    Prev. Close 140.87
    Today's Range 134.43 - 136.62
    52wk Range 77.95 - 148.15
    Shares Outstanding N/A
    Dividend Yield 1.31%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Forget Boring Diversification! 3 Wild-Card Stocks to Spice Up Your Portfolio
    These three wild-card stocks will spice up your portfolio in ways boring diversification never could, so read on. 
    Via InvestorPlace
    Novo Nordisk Faces Setback in Netherlands Over Wegovy Insurance Coverage
    Novo Nordisk expresses disappointment over the Dutch Health Care Institute's advice against including Wegovy in the Netherlands' basic insurance, citing unclear health benefits and high costs. 
    Via Benzinga

    Performance

    YTD
    +32.62%
    +32.62%
    1 Month
    -3.53%
    -3.53%
    3 Month
    +8.74%
    +8.74%
    6 Month
    +26.94%
    +26.94%
    1 Year
    +69.01%
    +69.01%

    More News

    Read More
    Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped
    Via The Motley Fool
    Pfizer And Roche Advance On Their Weight Loss Drug Journeys
    Via Benzinga
    Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
    Via Benzinga
    $1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth This Much Today
    Via Benzinga
    Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data
    Via Investor's Business Daily
    3 Hot Growth Stocks That Will Make You Forget About AMD
    Via InvestorPlace
    Senate To Review Novo Nordisk's Levemir Insulin Discontinuation
    Via Benzinga
    3 Dow Jones Stocks to Buy at 52-Week Lows in July
    Via InvestorPlace
    Topics Stocks
    Exposures US Equities
    Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
    Via Benzinga
    Topics Bankruptcy
    Exposures Financial Legal
    This Analyst Sees Potential Downside In Eli Lilly, Adjusts Model For Acquired IPR&D Charges
    Via Benzinga
    7 Top-Quality Stocks to Buy Now: July 2024
    Via InvestorPlace
    Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
    Via The Motley Fool
    2 Incredibly Cheap Growth Stocks to Buy Now
    Via The Motley Fool
    Is Eli Lilly a Good Dividend Stock to Buy Now?
    Via The Motley Fool
    This 1 Piece of Bad News for Novo Nordisk Is Good News for Eli Lilly Stock
    Via The Motley Fool
    Here's 80 Billion More Reasons to Buy Novo Nordisk Stock
    Via The Motley Fool
    The 7 Most Important Stocks to Watch as Q2 Earnings Season Kicks Off
    Via InvestorPlace
    Did Eli Lilly Just Get a Leg Up on Novo Nordisk?
    Via The Motley Fool
    The Weight Loss Market Can Surge To $400B By 2032, And These Stocks Will Rule It
    Via Talk Markets
    Novo Nordisk Stock Pops After Weight-Loss Drug Cuts Dementia Risk In Yearlong Study
    Via Investor's Business Daily
    Stock Market Shifts Toward Small Caps After Tame CPI; JPMorgan, Taiwan Semi, Tesla In Focus: Weekly Review
    Via Investor's Business Daily
    Using Ozempic, Zepbound Or Other Weight Loss Drugs? Inform Doctors Before Anesthesia Or Surgery, European Medicines Agency Issues Advisory
    Via Benzinga
    3 Global Stocks Worth Buying as America Stumbles
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.